ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: () Report Updated: Sep 22, 2014 | Print This Page

Get more stock ratings by Louis Navellier

(KNSY)

Rating: Volatility:
Total Grade: Industry:
Competitors:

Stock Analysis

Rating: Monthly View

A
B
C
D
F
September October November December January February March April May June July August

Rating: Weekly View

This Week: down no change
Last Week: same no change
Two Weeks Ago: up no change
service keys

© quotemedia

Company Profile

Kensey Nash Corporation, a medical device company, develops products and technologies in the fields of resorbable biomaterials and endovascular devices used in various medical procedures. The company develops, manufactures, and processes resorbable biomaterials products incorporating its proprietary collagen and synthetic polymer technology. It offers Angio-Seal components; orthopaedic products for various applications of biomaterials, which include soft tissue and bone fixation, and bone void fillers and scaffolds; and biomaterials-based products, including resorbable breast biopsy markers, dental barrier membranes, and wound care products designed for other market applications. The company sells its products to multiple medical markets, primarily in the cardiology, orthopaedic, sports medicine, spine, endovascular, and general surgery. The company distributes its endovascular products through direct sales force primarily in the United States and Germany, as well as through distributors in Europe, Russia, and India. It has strategic agreement with Synthes, Inc., under which the company would develop and manufacture porcine dermis-based Medeor matrix ECM products. The company was incorporated in 1984 and is headquartered in Exton, Pennsylvania.

Recent News: